Antidote Therapeutics, Inc. — Form D
Antidote Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-11. The offering totals $200K, of which $200K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-09-11
- Form: D
- Accession: 0001716110-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $200K
- Investors: 1
- Date of first sale: 2017-06-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-294374
Issuer
- Name: Antidote Therapeutics, Inc.
- CIK: 0001716110
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 708 QUINCE ORCHARD ROAD, GAITHERSBURG, MD, 20878
- Phone: 301-365-5385
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Kenneth C Carter | Director | SYKESVILLE, MD |
| Matthew W Kalnik, PhD | Director | Gaithersburg, MD |
| Matthew W Kalnik, PhD | Executive Officer | Gaithersburg, MD |
Other filings by this issuer (1)
More